Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-12
pubmed:abstractText
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an infantile autosomal-recessive motor neuron disease caused by mutations in the immunoglobulin micro-binding protein 2. We investigated the potential of a spinal cord neural stem cell population isolated on the basis of aldehyde dehydrogenase (ALDH) activity to modify disease progression of nmd mice, an animal model of SMARD1. ALDH(hi)SSC(lo) stem cells are self-renewing and multipotent and when intrathecally transplanted in nmd mice generate motor neurons properly localized in the spinal cord ventral horns. Transplanted nmd animals presented delayed disease progression, sparing of motor neurons and ventral root axons and increased lifespan. To further investigate the molecular events responsible for these differences, microarray and real-time reverse transcription-polymerase chain reaction analyses of wild-type, mutated and transplanted nmd spinal cord were undertaken. We demonstrated a down-regulation of genes involved in excitatory amino acid toxicity and oxidative stress handling, as well as an up-regulation of genes related to the chromatin organization in nmd compared with wild-type mice, suggesting that they may play a role in SMARD1 pathogenesis. Spinal cord of nmd-transplanted mice expressed high transcript levels for genes related to neurogenesis such as doublecortin (DCX), LIS1 and drebrin. The presence of DCX-expressing cells in adult nmd spinal cord suggests that both exogenous and endogenous neurogeneses may contribute to the observed nmd phenotype amelioration.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0964-6906
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
167-87
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16339214-1-Alkyl-2-acetylglycerophosphocholine Esterase, pubmed-meshheading:16339214-Aldehyde Dehydrogenase, pubmed-meshheading:16339214-Animals, pubmed-meshheading:16339214-Blotting, Western, pubmed-meshheading:16339214-Cells, Cultured, pubmed-meshheading:16339214-Disease Progression, pubmed-meshheading:16339214-Gene Expression Regulation, pubmed-meshheading:16339214-Immunohistochemistry, pubmed-meshheading:16339214-Mice, pubmed-meshheading:16339214-Mice, Mutant Strains, pubmed-meshheading:16339214-Microarray Analysis, pubmed-meshheading:16339214-Microtubule-Associated Proteins, pubmed-meshheading:16339214-Motor Neurons, pubmed-meshheading:16339214-Neuropeptides, pubmed-meshheading:16339214-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16339214-Spinal Cord, pubmed-meshheading:16339214-Spinal Muscular Atrophies of Childhood, pubmed-meshheading:16339214-Stem Cell Transplantation, pubmed-meshheading:16339214-Stem Cells, pubmed-meshheading:16339214-Survival Analysis
pubmed:year
2006
pubmed:articleTitle
Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1.
pubmed:affiliation
Dino Ferrari Centre, Department of Neurological Sciences, University of Milan, IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Milan, Italy.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't